Bandingkan Harga & Kinerja Diagnos Laboratorium Utama Tbk. (DGNS) vs Tempo Scan Pacific Tbk. (TSPC)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Diagnos Laboratorium Utama Tbk. dan Tempo Scan Pacific Tbk.: Diagnos Laboratorium Utama Tbk. diperdagangkan di Rp230 (kapitalisasi pasar 321,75 M, volume 24 jam 152,8 rb), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.790 (kapitalisasi pasar 12,58 T, volume 24 jam 809,6 rb). Perbedaan utamanya: Tempo Scan Pacific Tbk. jauh lebih besar — sekitar 39,1× kapitalisasi pasar Diagnos Laboratorium Utama Tbk., dan Tempo Scan Pacific Tbk. lebih aktif diperdagangkan (809,6 rb vs 152,8 rb). Mana yang lebih baik tergantung tujuan investasimu.
| DGNS | TSPC | |
|---|---|---|
Kapitalisasi Pasar | 321,75 M | 12,58 T |
Volume | 152,8 rb | 809,6 rb |
Lot | 1,53 rb | 8,1 rb |
Perputaran | 35,37 jt | 2,26 M |
Harga Rata-rata | 231,49 | 2.786,16 |
Nilai Transaksi | 35,37 jt | 2,26 M |
Harga Ekuilibrium Indikatif | 230 | 2.790 |
Volume Ekuilibrium Indikatif | 1 | 1,63 rb |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Selengkapnya di halaman DGNS →Tentang Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Selengkapnya di halaman TSPC →
